| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5269325
Max Phase: Preclinical
Molecular Formula: C28H25F3O5
Molecular Weight: 498.50
Associated Items:
Representations
Canonical SMILES: COc1cc(O)c(C(=O)O)c(CC(=O)c2cccc(-c3cccc(C(F)(F)F)c3)c2)c1CC=C(C)C
Standard InChI: InChI=1S/C28H25F3O5/c1-16(2)10-11-21-22(26(27(34)35)24(33)15-25(21)36-3)14-23(32)19-8-4-6-17(12-19)18-7-5-9-20(13-18)28(29,30)31/h4-10,12-13,15,33H,11,14H2,1-3H3,(H,34,35)
Standard InChI Key: UPTDGFOQDULOTH-UHFFFAOYSA-N
Associated Targets(Human)
Peroxisome proliferator-activated receptor gamma 15191 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 498.50 | Molecular Weight (Monoisotopic): 498.1654 | AlogP: 6.72 | #Rotatable Bonds: 8 |
| Polar Surface Area: 83.83 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 2.83 | CX Basic pKa: | CX LogP: 7.47 | CX LogD: 3.97 |
| Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.27 | Np Likeness Score: 0.30 |
References
| 1. Xu XT, Shi LY, Ban YJ, Luo BL, Zhu GF, Guo B, Tang L, Sang ZP, Wang JT.. (2023) Design, synthesis and biological evaluation of cajanonic acid A analogues as potent PPAR γ antagonists., 80 [PMID:36414176] [10.1016/j.bmcl.2022.129081] |
Source
Source(1):